このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Quest Diagnostics マネジメント
マネジメント 基準チェック /44
Quest Diagnostics'の CEO はJim Davisで、 Nov2022年に任命され、 の在任期間は 1.75年です。 の年間総報酬は$ 12.67Mで、 9.3%給与と90.7%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.067%を直接所有しており、その価値は$ 11.31M 。経営陣と取締役会の平均在任期間はそれぞれ3.7年と5年です。
主要情報
Jim Davis
最高経営責任者
US$12.7m
報酬総額
| CEO給与比率 | 9.3% |
| CEO在任期間 | 1.8yrs |
| CEOの所有権 | 0.07% |
| 経営陣の平均在職期間 | 3.8yrs |
| 取締役会の平均在任期間 | 5yrs |
経営陣の近況
Recent updates
These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well
Aug 30
Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?
Aug 12Quest Diagnostics: Beat Down After Beating Q2 Estimates
Jul 28The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)
Jul 12Quest Diagnostics: On A Quest For Growth
Jul 12Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns
May 14Quest Diagnostics: Let's Keep Waiting
May 08Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts
Apr 26We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt
Apr 23Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares
Apr 02Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year
Mar 15Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75
Feb 06Quest Diagnostics: Post-COVID Normalization Pretty Much Done
Feb 05Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 11Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price
Dec 24Quest Diagnostics: Market Overreaction Creates Investment Opportunity
Dec 08Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?
Dec 06Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall
Nov 18Quest Diagnostics: Moving Past Covid
Oct 25Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly
Sep 25What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Sep 04Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues
Aug 15Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
Aug 13Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate
Jul 11Is Quest Diagnostics (NYSE:DGX) A Risky Investment?
Jun 09Quest Diagnostics: Healthier Diagnosis
May 30Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?
May 24Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
May 09An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued
Mar 22What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Feb 19Why Quest Diagnostics Isn't A 'Buy', My Oh My
Feb 14Quest Diagnostics' (NYSE:DGX) Upcoming Dividend Will Be Larger Than Last Year's
Feb 05Quest Diagnostics Q4 2022 Earnings Preview
Feb 01Quest Diagnostics' unit Pack Health to expand Alabama facility
Jan 17Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 17Returns On Capital Are Showing Encouraging Signs At Quest Diagnostics (NYSE:DGX)
Jan 03An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 46% Undervalued
Dec 04CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$836m |
| Mar 31 2024 | n/a | n/a | US$842m |
| Dec 31 2023 | US$13m | US$1m | US$850m |
| Sep 30 2023 | n/a | n/a | US$759m |
| Jun 30 2023 | n/a | n/a | US$790m |
| Mar 31 2023 | n/a | n/a | US$789m |
| Dec 31 2022 | US$12m | US$806k | US$942m |
| Sep 30 2022 | n/a | n/a | US$1b |
| Jun 30 2022 | n/a | n/a | US$1b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | US$4m | US$625k | US$2b |
| Sep 30 2021 | n/a | n/a | US$2b |
| Jun 30 2021 | n/a | n/a | US$2b |
| Mar 31 2021 | n/a | n/a | US$2b |
| Dec 31 2020 | US$4m | US$577k | US$1b |
| Sep 30 2020 | n/a | n/a | US$1b |
| Jun 30 2020 | n/a | n/a | US$749m |
| Mar 31 2020 | n/a | n/a | US$771m |
| Dec 31 2019 | US$3m | US$590k | US$835m |
| Sep 30 2019 | n/a | n/a | US$709m |
| Jun 30 2019 | n/a | n/a | US$707m |
| Mar 31 2019 | n/a | n/a | US$720m |
| Dec 31 2018 | US$3m | US$590k | US$733m |
| Sep 30 2018 | n/a | n/a | US$860m |
| Jun 30 2018 | n/a | n/a | US$808m |
| Mar 31 2018 | n/a | n/a | US$782m |
| Dec 31 2017 | US$3m | US$590k | US$769m |
報酬と市場: Jimの 総報酬 ($USD 12.67M ) は、 US市場 ($USD 13.21M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Jimの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Jim Davis (61 yo)
1.8yrs
在職期間
US$12,673,834
報酬
Mr. James E. Davis, also known as Jim, serves as Chief Executive Officer and President at Quest Diagnostics Incorporated since November 1, 2022 and serves as its Director since November 2022. He served as...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman | 1.8yrs | US$12.67m | 0.067% $ 11.6m | |
| Executive VP & CFO | 2.2yrs | US$3.98m | 0.016% $ 2.7m | |
| Senior VP & General Counsel | 25.1yrs | US$2.25m | 0.040% $ 6.8m | |
| Executive Vice President of Regional Businesses | no data | US$3.16m | 0.058% $ 10.0m | |
| Senior Vice President of Clinical Solutions | 2.1yrs | US$2.02m | 0.012% $ 2.1m | |
| Senior VP | 5.4yrs | データなし | 0.032% $ 5.5m | |
| Senior VP | less than a year | データなし | データなし | |
| Vice President of Investor Relations | no data | データなし | データなし | |
| Senior VP & Chief Compliance Officer | 1.9yrs | データなし | データなし | |
| Senior VP & Chief Communications Officer | 27.8yrs | データなし | データなし | |
| Senior VP & Chief Human Resources Officer | 6.6yrs | データなし | データなし | |
| Senior Vice President of Strategy | 8.6yrs | データなし | データなし |
3.8yrs
平均在職期間
61yo
平均年齢
経験豊富な経営陣: DGXの経営陣は 経験豊富 であると考えられます ( 3.7年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman | 1.8yrs | US$12.67m | 0.067% $ 11.6m | |
| Independent Director | 10.7yrs | US$315.44k | 0.023% $ 3.9m | |
| Director | less than a year | データなし | データなし | |
| Lead Independent Director | 12.8yrs | US$345.94k | データなし | |
| Independent Director | 19.8yrs | US$342.12k | データなし | |
| Independent Director | 5.6yrs | US$312.33k | 0.0026% $ 443.5k | |
| Independent Director | 10.2yrs | US$315.73k | 0.016% $ 2.8m | |
| Independent Director | 4.5yrs | US$300.44k | データなし | |
| Independent Director | 3.1yrs | US$300.44k | データなし | |
| Independent Director | 1.3yrs | US$280.41k | データなし |
5.0yrs
平均在職期間
65yo
平均年齢
経験豊富なボード: DGXの 取締役会 は 経験豊富 であると考えられます ( 5年の平均在任期間)。